1. Home
  2. STVN vs ICL Comparison

STVN vs ICL Comparison

Compare STVN & ICL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • ICL
  • Stock Information
  • Founded
  • STVN 1949
  • ICL 1968
  • Country
  • STVN Italy
  • ICL Israel
  • Employees
  • STVN N/A
  • ICL N/A
  • Industry
  • STVN Containers/Packaging
  • ICL Agricultural Chemicals
  • Sector
  • STVN Consumer Discretionary
  • ICL Industrials
  • Exchange
  • STVN Nasdaq
  • ICL Nasdaq
  • Market Cap
  • STVN 7.4B
  • ICL 8.6B
  • IPO Year
  • STVN 2021
  • ICL N/A
  • Fundamental
  • Price
  • STVN $22.87
  • ICL $5.52
  • Analyst Decision
  • STVN Buy
  • ICL Hold
  • Analyst Count
  • STVN 4
  • ICL 3
  • Target Price
  • STVN $25.88
  • ICL $6.23
  • AVG Volume (30 Days)
  • STVN 360.6K
  • ICL 910.1K
  • Earning Date
  • STVN 11-06-2025
  • ICL 11-12-2025
  • Dividend Yield
  • STVN 0.27%
  • ICL 3.50%
  • EPS Growth
  • STVN 19.61
  • ICL N/A
  • EPS
  • STVN 0.60
  • ICL 0.29
  • Revenue
  • STVN $1,373,219,524.00
  • ICL $7,053,000,000.00
  • Revenue This Year
  • STVN $8.33
  • ICL $6.36
  • Revenue Next Year
  • STVN $10.12
  • ICL $5.29
  • P/E Ratio
  • STVN $38.31
  • ICL $19.27
  • Revenue Growth
  • STVN 6.97
  • ICL 1.77
  • 52 Week Low
  • STVN $17.81
  • ICL $4.52
  • 52 Week High
  • STVN $28.00
  • ICL $7.35
  • Technical
  • Relative Strength Index (RSI)
  • STVN 45.20
  • ICL 39.90
  • Support Level
  • STVN $20.67
  • ICL $5.27
  • Resistance Level
  • STVN $24.01
  • ICL $5.56
  • Average True Range (ATR)
  • STVN 1.23
  • ICL 0.12
  • MACD
  • STVN 0.06
  • ICL -0.00
  • Stochastic Oscillator
  • STVN 45.08
  • ICL 55.91

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

Share on Social Networks: